Trial could unlock asthma use for GSK’s TrelegyGlaxoSmithKline CEO Emma Walmsley has been predicting big things for respiratory triple therapy Trelegy in the next couple Share XTrial could unlock asthma use for GSK’s Trelegyhttps://pharmaphorum.com/news/trial-could-unlock-asthma-use-for-gsks-trelegy/
